NOTCH1 and acute lymphoblastic leukemia: Most notably, in that scenario, eradication of the quiescent and chemo-resistant pre-LSCs by inactivation of NOTCH signaling might be applicable for a large fraction of primary human T-ALL patients, irrespective of their NOTCH1 mutational status at diagnosis.